Nate Larson
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Outbreaks Research
- Viral gastroenteritis research and epidemiology
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 7
-
- Cell Adhesion Molecules Research 2
- Co-authors
- Hamidreza Ghandehari (10 shared papers)Abhijit Ray (7 shared papers)Adam J. Gormley (3 shared papers)Ryan Robinson (2 shared papers)Shraddha Sadekar (1 shared paper)Hillevi Bauer (3 shared papers)Khaled F. Greish (3 shared papers)Alexander Malugin (3 shared papers)
- Journals
- Journal of Controlled Release (3 papers)International Journal of Pharmaceutics (2 papers)Nano Today (1 paper)Macromolecular Bioscience (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Nate Larson
12 papers receiving 2.2k citations
Nate Larson's Hit Papers
Peers
Comparison fields: 5 of 112
- Infectious Diseases 930
- Biomaterials 570
- Pharmaceutical Science 76
- Modeling and Simulation 45
- Biomedical Engineering 431
Countries citing papers authored by Nate Larson
This map shows the geographic impact of Nate Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nate Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nate Larson more than expected).
Fields of papers citing papers by Nate Larson
This network shows the impact of papers produced by Nate Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nate Larson. The network helps show where Nate Larson may publish in the future.
Co-authors
The 17 scholars most cited alongside Nate Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys Hit paper breakdown → | 2016 | 1254 |
| 2 | Polymeric Conjugates for Drug Delivery Hit paper breakdown → | 2012 | 518 |
| 3 | 2012 | 111 | |
| 4 | 2012 | 62 | |
| 5 | 2011 | 53 | |
| 6 | 2013 | 52 | |
| 7 | 2013 | 50 | |
| 8 | 2011 | 40 | |
| 9 | 2011 | 38 | |
| 10 | 2010 | 31 | |
| 11 | 2018 | 14 | |
| 12 | 2014 | 8 |
About Nate Larson
Nate Larson is a scholar working on Biomaterials, Immunology and Allergy, Biomedical Engineering, Electronic, Optical and Magnetic Materials and Molecular Biology, having authored 12 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers), Prostate Cancer Treatment and Research (2 papers), Cell Adhesion Molecules Research (2 papers), Gold and Silver Nanoparticles Synthesis and Applications (2 papers), RNA Interference and Gene Delivery (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Infectious Diseases (930 citations), Biomaterials (570 citations), Pharmaceutical Science (76 citations), Modeling and Simulation (45 citations) and Biomedical Engineering (431 citations). Nate Larson has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Hamidreza Ghandehari, Abhijit Ray, Adam J. Gormley, Ryan Robinson, Shraddha Sadekar, Hillevi Bauer, Khaled F. Greish, Alexander Malugin, Daniel B. Pike and Darwin L. Cheney. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Nano Today, Macromolecular Bioscience and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.